107 related articles for article (PubMed ID: 10573138)
1. An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection.
Galimberti S; Brizzi F; Mameli M; Petrini M
Leuk Res; 1999 Oct; 23(10):921-9. PubMed ID: 10573138
[TBL] [Abstract][Full Text] [Related]
2. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
4. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
Zwicky CS; Maddocks AB; Andersen N; Gribben JG
Blood; 1996 Nov; 88(9):3314-22. PubMed ID: 8896395
[TBL] [Abstract][Full Text] [Related]
5. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions.
Linke B; Bolz I; Pott C; Hiddemann W; Kneba M
Leukemia; 1995 Dec; 9(12):2133-7. PubMed ID: 8609729
[TBL] [Abstract][Full Text] [Related]
6. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
[TBL] [Abstract][Full Text] [Related]
7. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
[TBL] [Abstract][Full Text] [Related]
9. Improvement of clonality detection rate in multiple myeloma using fluorescent IgH PCR with different sets of primers.
Welterlin V; Debecker A; Tschieb D; Zanetti C; Lange W; Hénon PR
J Hematother Stem Cell Res; 2000 Dec; 9(6):983-91. PubMed ID: 11177613
[TBL] [Abstract][Full Text] [Related]
10. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma.
Abdel-Reheim FA; Edwards E; Arber DA
Arch Pathol Lab Med; 1996 Apr; 120(4):357-63. PubMed ID: 8619747
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
[TBL] [Abstract][Full Text] [Related]
12. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease.
Orazi A; Jiang B; Lee CH; English GW; Cattoretti G; John K; Neiman RS
Am J Clin Pathol; 1995 Oct; 104(4):413-8. PubMed ID: 7572791
[TBL] [Abstract][Full Text] [Related]
13. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
[TBL] [Abstract][Full Text] [Related]
14. [Detection of IgH gene rearrangement in B-cell non-Hodgkin's lymphoma and application of gel-scan method].
Zhang XF; Zhou R; Mao ZR; Luo LK; Hu MJ; Yang SY; Li FM
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):513-7. PubMed ID: 15634445
[TBL] [Abstract][Full Text] [Related]
15. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection].
Yao L; Chen ZX; Cen JN; Liu H; He J; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):433-7. PubMed ID: 21122394
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin gene rearrangement in detection of minimal residual disease in acute lymphoblastic leukaemia.
Nayyar A; Ahmed S
J Ayub Med Coll Abbottabad; 2013; 25(1-2):159-61. PubMed ID: 25098084
[TBL] [Abstract][Full Text] [Related]
18. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
[TBL] [Abstract][Full Text] [Related]
19. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
[TBL] [Abstract][Full Text] [Related]
20. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL.
Chim JC; Coyle LA; Yaxley JC; Cole-Sinclair MF; Cannell PK; Hoffbrand VA; Foroni L
Br J Haematol; 1996 Jan; 92(1):104-15. PubMed ID: 8562380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
